Supreme Court victory hinged on evidence of racism

Cornell University
12-Dec-2019 2:15 PM EST, by Cornell University

Newswise — On the morning of July 16, 1996, four employees of the Tardy Furniture store in downtown Winona, Mississippi, were shot in the head, their bodies left sprawled on the floor or slumped over the counter.

Seven months later, Curtis Flowers, an employee who had been fired from the store two weeks before the murders, was arrested and charged with the quadruple homicide. Flowers, 26 at the time, had no criminal record, and no forensic evidence linked him to the killings.

Yet six times over the next 14 years, the Montgomery County prosecutor, Doug Evans, tried Flowers, an African American who had grown up in Winona. The first three trials ended with a conviction and death sentence but were overturned by the Mississippi Supreme Court because of prosecutorial misconduct or because prospective jurors had been excluded based on their race. The next two were mistrials. In the sixth trial, Flowers was again convicted and sentenced to death.

Flowers wanted to appeal, and two Cornell Law School professors – Sheri Lynn Johnson and Keir Weyble – agreed to take over the case. Working with two students from the Law School’s capital punishment clinic, they took the case to the U.S. Supreme Court. On June 21, 2019, in a 7–2 decision, the court overturned the conviction. The justices concluded that Evans had violated the U.S. Constitution by repeatedly excluding African Americans during jury selection, using what is known as peremptory challenges.

While Flowers is still imprisoned and may face a seventh trial in Mississippi, the Supreme Court decision will have a significant impact on future cases dealing with racial bias in the selection of jurors, said John Blume, the Samuel F. Leibowitz Professor of Trial Techniques and director of the Cornell Death Penalty Project. “I think the court,” Blume said, “is trying to send a message: ‘Don’t do this. … Don’t cheat to win.’” 

Johnson, the James and Mark Flanagan Professor of Law, is a renowned expert on the interface of race and criminal procedure. And Weyble, clinical professor of law, is a nationally known expert in post-conviction litigation and has represented prisoners in capital cases across the South for more than 20 years.

Both were attracted to the case because of its focus on racial issues in jury selection and the sheer number of trials involved. “I’d never encountered another case that went to trial six times,” Weyble said. “That alone made my ears perk up.”

As they began researching the case, they found overwhelming evidence of racial discrimination: Out of the 43 African Americans in the jury pool for Flowers’ six trials, Evans rejected 41. And in the sixth trial, he struck five of six.

“The numbers are extraordinary,” Johnson said. “For whatever reason, Evans wanted a white jury and did whatever he could to get his white jury.”

They also found Evans used weak evidence in the case. For example, one witness could only identify the perpetrator as being African American and initially named someone else as the suspect, Johnson said.

“He only [identified] Mr. Flowers after there were various suggestive comments made,” Johnson said. “So a variety of factors made this an unreliable identification and in our view should have meant that the identification should not have gone to the jury at all.”

When the Mississippi Supreme Court reaffirmed Flowers’ conviction in his sixth trial, Johnson and Weyble appealed to the U.S. Supreme Court. But the court sent the case back to the lower court. 

As they prepared their second appeal to the U.S. Supreme Court, Johnson and Weyble enlisted Pablo Chapablanco, J.D. ’19, and Sam Macomber, J.D. ’20, students in the school’s capital punishment clinic. During the fall and spring of 2018-19, Chapablanco and Macomber worked late into the night, poring over the jury selection records and preparing a 600-page research document that would become an essential part of the arguments made to the Supreme Court. “They did extraordinary work on behalf of Curtis Flowers,” Johnson said. 

When the team filed its petition to the Supreme Court, it focused on a single issue: whether the prosecutor deliberately used race to exclude prospective jurors in the sixth trial. They pointed to the Supreme Court’s 1986 decision in Batson v. Kentucky, where it ruled that prosecutors may not exclude jurors solely on the basis of race because it violates the 14th Amendment.

They also pointed to another hallmark of racial discrimination in jury selection: questioning potential jurors differently. While Evans asked both African Americans and whites about their relationships to Flowers and witnesses in the case, he asked only prospective African American jurors details about those relationships.

“The prosecutor dug very deep to find those potential biases in the jurors, but he did not ask those probing questions of white potential jurors,” said Macomber. “So the whole point was the prosecutor was striking jurors and giving some reason, and that was a pretext for race.”

On Nov. 2, 2018 – five months after the legal team had filed its petition – the Supreme Court agreed to hear Flowers’ appeal. The team had 40 business days to file the brief on the case.

While they had accumulated a set of written arguments over their six years of work on the case, preparing a brief for the Supreme Court “requires a deeper dive” on the key issues, Weyble said. They started a new brief from scratch. On Dec. 27, 2018, the team filed the brief, and began waiting for its day in court.

On the day of the hearing, Johnson presented her argument, focusing on the issue of racial bias. “The only plausible interpretation of all of the evidence viewed cumulatively is that Doug Evans began jury selection in Flowers VI with an unconstitutional end in mind, to seat as few African American jurors as he could,” she said.

Associate Justice Samuel A. Alito Jr. asked Johnson if she thought she would have a chance of winning the case solely on the basis of the striking of African American jurors in the sixth trial, without the history of the previous trials. 

Over the course of the hourlong hearing, the questions from Kavanaugh and Alito surprised Johnson the most. “They’re very conservative justices, and so I would not have expected them to be sympathetic to any claim of a criminal defendant,” she said.

Before the hearing was over, Weyble said it was apparent that the decision would turn in their favor. “It seemed pretty clear early on in the argument that the court understood what was going on in the case,” he said.

When the decision was announced last June, neither Weyble nor Johnson was surprised that Kavanaugh had written it. In his 31-page decision, he wrote, “In sum, the state’s pattern of striking black prospective jurors persisted from Flowers’ first trial through Flowers’ sixth trial.” He concluded that “we break no new legal ground. We simply enforce and reinforce Batson by applying it to the extraordinary facts of this case.”

The Supreme Court sent the case back to Mississippi Supreme Court for “further proceedings”; the decision of whether to release Flowers or to try him yet again lies with Evans, the prosecutor. Evans hasn’t said whether he will try Flowers again but has stated he remains convinced Flowers is guilty.

If he does try Flowers again, however, he will have fewer witnesses to prove his case. In the past two years, a jailhouse informant who claimed that Flowers had confessed and a woman who claimed that she saw Flowers running from the murder scene have recanted their testimony.

“The case has certainly gotten much weaker in the nine years since it was tried last,” said Weyble, who, like Johnson, believes Flowers is innocent. “If I were a prosecutor, I would think pretty seriously about whether I’m just going to embarrass myself by trying this case again.”

Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.

Showing results

110 of 4573